Meeting
2022 ASCO Annual Meeting
Renal cell carcinoma in renal transplant recipients: Is there a role for screening?
Authors
Binoy Yohannan
U. Texas Medical School, Houston, TX
Binoy Yohannan , Arthi Sridhar , Harmanpreet Kaur , Aleksandra De Golovine , Neha Maithel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10528)
DOI
10.1200/JCO.2022.40.16_suppl.10528
Abstract #
10528
Poster Bd #
405
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world outcomes of patients with operable renal cell carcinoma from the German translational cancer research consortium (DKTK) network.
First Author: Viktor Grünwald
Poster
2024 ASCO Genitourinary Cancers Symposium
Neoadjuvant pembrolizumab (PEMBRO) and axitinib (AXI) in renal cell carcinoma with associated inferior vena cava tumor thrombus (NEOPAX).
First Author: Stephanie Lakritz
Poster
2022 ASCO Genitourinary Cancers Symposium
Characterization of aberrant alternative splicing landscape in patients with renal cell carcinoma (RCC).
First Author: Ameish Govindarajan
Poster
2021 ASCO Annual Meeting
Impact of disruptions in breast cancer control due to the COVID-19 pandemic on breast cancer mortality in the United States: Estimates from collaborative simulation modeling.
First Author: Oguzhan Alagoz